California Gold Mining Full Speed Ahead in Hemp

Contributed Opinion
  ()
Peter Epstein of Epstein Research provides an update on a mining exploration company that is diversifying into the hemp market. read more >

Developer of Cannabinoid-Based Drugs to Resume Cancer Pain Trial

Research Report
  ()
Calling this latest development "excellent news," Paradigm Capital has raised its target price on the company's stock. read more >

Analyst: Biopharma, Now Stronger Than Ever, Is an Ideal Takeout Target

Research Report
  ()
An argument is made in a ROTH Capital Partners report for a potential imminent deal involving this drug maker. read more >

Immunotherapeutic Agent Shows Efficacy in Rare Respiratory Disease

Research Report
  ()
Trial results for this therapeutic, and their implications for this biotech, were discussed in an H.C. Wainwright & Co. report. read more >
News Update

Augmented Reality Firm Moves into Medical Devices Arena

News Update
  ()
This technology company continues to diversify the end markets for its e-commerce platform. read more >
News Update

Canadian Tech Firm Secures Largest Contract to Date

News Update
  ()
The new client, in the U.S., is a state governmental agency. read more >
News Update

Biotech Achieves Development Milestone for Blue Light Imaging System

News Update
  ()
The surgical imaging firm continues to advance its first medical device toward commercialization. read more >
News Update

Innovative Healthcare Tech Firm to Acquire Two Vancouver Pharmacies

News Update
  ()
The transaction will allow the company to add a prescription fill and fulfillment component to its telemedicine app. read more >

Biopharma Expects Data Readouts in Psoriasis, NASH in H2/19

Research Report
  ()
Two recently launched clinical trials, and related conference calls, were reviewed in an H.C. Wainwright & Co. report. read more >

Best-of-Breed Hemp/CBD Producers

Contributed Opinion
  ()
Fincom Investment Partners surveys the hemp-CBD landscape and discusses two companies it believes are "best of breed." read more >

Expert Investing Ideas

"DRRX's current valuation is an interesting buying opportunity."

–Francois Brisebois, Laidlaw & Company


"SPR is the number one cannabis stock to own today."

–Cynthia Berryman, Financial News Now


"DRRX's Posimir comes back in play."

–Ed Arce, H.C. Wainwright & Co.


"We expect PMN to forge a licensing deal in Q2/19 or Q3/19."

–André Uddin, Mackie Research Capital


"I'm excited about the new team Sproutly is bringing on."

–Jimmy Mengel, Marijuana Minifesto


"VIV signed a partnership with CSA Animal Nutrition."

–Alex Koyfman, Penny Stock Millionaire


"We are initiating coverage on PMN with an Outperform rating."

–Cosme Ordonez, Noble Capital Markets


Get Our Streetwise Reports Life Sciences Report Newsletter Free and be the first to know!

A valid email address is required to subscribe
NASDAQ Biotech ARCA Pharmaceutical

First Cobalt Corp., Oversold, Poised for Rebound This Year?

Contributed Opinion
  ()
Peter Epstein of Epstein Research discusses the market for cobalt and profiles one company whose shares he believes could be at an attractive entry point. read more >

Biopharma's Early Data Show Immunotherapy's Efficacy in Ovarian Cancer

Research Report
  ()
The "encouraging" data for this drug candidate as a monotherapy is the focus of an H.C. Wainwright & Co. report. read more >
News Update

Firm Signs Paid Pilot Agreements to Test Telemedicine Platform in 5 States

News Update
  ()
With this development, the Canadian company further expands its U.S. footprint. read more >
News Update

Biopharma Hits Milestone in Starting Enrollment for NASH Clinical Trial

News Update
  ()
The company will discuss the trial when it hosts a conference call about this specific disease indication in April. read more >